HPV vaccine coverage among female adolescents by age U.S. 2021

As of 2021, around 82.3 percent of female adolescents aged 17 years in the U.S. had received one or more doses of an HPV vaccine. This statistic shows the percentage of female adolescents in the U.S. who had received a human papillomavirus (HPV) vaccine as of 2021, by age.

Percentage of female adolescents in the U.S. who had received an HPV vaccine as of 2021, by age*

Age	13 years	14 years	15 years	16 years	17 years	Total
One or more doses	73.7%	75.6%	82.4%	79.2%	82.3%	78.5%
UTD**	50.1%	61.5%	68.6%	69%	70.6%	63.8%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

September 2022

More information

Region

United States

Survey time period

2021

Number of respondents

18,002 adolescents

Age group

13-17 years

Special properties

parents and guardians of adolescents

Method of interview

Telephone interview

Supplementary notes

* HPV vaccine, nine–valent (9vHPV), quadrivalent (4vHPV), or bivalent (2vHPV).
** UTD = up-to-date. HPV UTD includes those with ≥3 doses, and those with 2 doses when the first HPV vaccine dose was initiated at age <15 years and at least 5 months minus 4 days elapsed between the first and second dose. This update to the HPV recommendation occurred in December of 2016.

Citation formats